申报总数
公司
▲ 买入(0 笔)
▼ 卖出(0 笔)
最新申报发布于 2026年5月01日(Arovella Therapeutics Limited)。
David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust:交易记录概览
目前只知道David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust的一份申报(2026年5月1日):Arovella Therapeutics Limited的一笔交易。数据太少,无法得出结论。以上数据均来自ASX发布的申报,描述的是过去的情况,不代表未来股价走势,也不构成投资建议。
与 David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust 相关的公司和市场
打开公司页面,查看内部人交易、基本面数据以及分析师一致预期(如有)。
申报1 总计
- 股票ASXISIN AU0000182784ASX:2924-03085488-3A692486
1 条申报中的 1 条